Nsclc pancreatic adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Pancreas Pancreatic Ducts Tumor Cells, Cultured Ampulla of Vater Pancreatic Juice Cardia Esophagogastric Junction Neoplastic Stem Cells Celiac Plexus Clavicle Stromal Cells Cell Line Esophagus Portal Vein

Organisms5

Mice, Nude Mice, SCID Mesocricetus Mice, Inbred BALB C Mice, Inbred C57BL

Diseases59

Adenocarcinoma Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Adenocarcinoma, Mucinous Pancreatitis, Chronic Adenocarcinoma, Papillary Lung Neoplasms Pancreatitis Adenocarcinoma, Bronchiolo-Alveolar Esophageal Neoplasms Carcinoma in Situ Barrett Esophagus Neoplasm Invasiveness Stomach Neoplasms Neoplasm Metastasis Disease Progression Carcinoma, Acinar Cell Precancerous Conditions Common Bile Duct Neoplasms Colonic Neoplasms Lymphatic Metastasis Carcinoma, Islet Cell Carcinoma, Squamous Cell Carcinoma, Large Cell Hematemesis Gastrointestinal Neoplasms Neoplasms, Experimental Neoplasm Recurrence, Local Carcinoma Endometrial Neoplasms Neoplasms, Multiple Primary Cell Transformation, Neoplastic Liver Neoplasms Intestinal Neoplasms Disease Models, Animal Prostatic Neoplasms Neovascularization, Pathologic Duodenal Neoplasms Carcinoma, Signet Ring Cell Carcinoma, Endometrioid Cecal Neoplasms Carcinoma, Adenosquamous Carcinoma, Small Cell Mammary Neoplasms, Experimental Adenocarcinoma, Clear Cell Metaplasia Colorectal Neoplasms Rectal Neoplasms Pancreatic Diseases Genetic Predisposition to Disease Cholangiocarcinoma Ileal Neoplasms Adenoma Carcinoma, Papillary Jejunal Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms Chronic Disease Paranasal Sinus Neoplasms

Chemicals and Drugs70

Deoxycytidine CA-19-9 Antigen Tumor Markers, Biological Antimetabolites, Antineoplastic Mucin-4 Keratin-7 Antineoplastic Agents Smad4 Protein Antigens, Neoplasm Fluorouracil HMGA1a Protein GPI-Linked Proteins DNA, Neoplasm Receptor, Epidermal Growth Factor RNA, Messenger Neoplasm Proteins Cisplatin Mucins Dithizone Mucin-1 ras Proteins HMGA Proteins Carcinoembryonic Antigen Proto-Oncogene Proteins Antigens, CD24 Quinazolines RNA, Neoplasm Antibodies, Monoclonal Ribonucleoside Diphosphate Reductase Organoplatinum Compounds Equilibrative Nucleoside Transporter 1 Tumor Suppressor Protein p53 Antigens, CD44 Keratins Cyclooxygenase 2 RNA, Small Interfering Receptor, Cholecystokinin B Cyclin-Dependent Kinase Inhibitor p16 Proto-Oncogene Proteins c-akt alpha-L-Fucosidase Codon Leucovorin Membrane Proteins Osteonectin DNA-Binding Proteins Receptors, Vasoactive Intestinal Peptide DNA Primers Vascular Endothelial Growth Factor A Protein Kinase Inhibitors Receptors, Cholecystokinin Receptor, Cholecystokinin A Cyclin-Dependent Kinase Inhibitor p27 Hedgehog Proteins Keratin-20 MicroRNAs BRCA2 Protein Osteopontin Antibodies, Monoclonal, Humanized Camptothecin Cell Adhesion Molecules Paclitaxel Transcription Factors Vinblastine Protein-Serine-Threonine Kinases Carboplatin Proto-Oncogene Proteins c-bcl-2 Taxoids Membrane Glycoproteins Carrier Proteins Antigens, CD

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Pancreaticoduodenectomy Pancreatectomy Immunohistochemistry Prognosis Survival Rate Treatment Outcome Survival Analysis Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Kaplan-Meier Estimate Neoplasm Transplantation Tissue Array Analysis Combined Modality Therapy Retrospective Studies Radiotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Immunoenzyme Techniques Chemoradiotherapy, Adjuvant Transplantation, Heterologous Disease-Free Survival Gene Expression Profiling Tomography, X-Ray Computed Blotting, Western Endosonography Xenograft Model Antitumor Assays Proportional Hazards Models Neoadjuvant Therapy Oligonucleotide Array Sequence Analysis Palliative Care Polymerase Chain Reaction Sensitivity and Specificity Predictive Value of Tests Multivariate Analysis Case-Control Studies Biopsy, Needle Neoplasms, Experimental Tumor Burden Risk Factors Fatal Outcome Biopsy, Fine-Needle Follow-Up Studies Clinical Trials, Phase I as Topic Flow Cytometry Positron-Emission Tomography DNA Mutational Analysis Transfection Paraffin Embedding Prospective Studies Infusions, Intravenous Disease Models, Animal In Situ Hybridization, Fluorescence SEER Program Drug Administration Schedule Mammary Neoplasms, Experimental Reproducibility of Results Risk Assessment Chi-Square Distribution Drug Delivery Systems Pneumonectomy In Situ Hybridization Cohort Studies Enzyme-Linked Immunosorbent Assay Incidence Immunoblotting Biopsy Gastrectomy Treatment Failure

Psychiatry and Psychology2

Smoking Treatment Refusal

Phenomena and Processes35

Gene Expression Regulation, Neoplastic Genes, ras Cell Proliferation Mutation Apoptosis Drug Resistance, Neoplasm Time Factors Sensitivity and Specificity Signal Transduction RNA Interference Up-Regulation Cell Division Genes, Tumor Suppressor DNA Methylation Base Sequence Codon Transfection Dose-Response Relationship, Drug Cell Movement Gene Amplification Cell Survival Drug Synergism Cell Cycle Gene Silencing Point Mutation Genes, erbB-1 Gene Expression Phosphorylation Genetic Predisposition to Disease Chi-Square Distribution Down-Regulation Promoter Regions, Genetic Genotype Gene Deletion Homozygote

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Treatment Refusal

Information Science6

Survival Rate Fatal Outcome Base Sequence Molecular Sequence Data SEER Program Incidence

Health Care27

Survival Rate Treatment Outcome Survival Analysis Kaplan-Meier Estimate Retrospective Studies Disease-Free Survival Proportional Hazards Models Palliative Care Congresses as Topic Sensitivity and Specificity Predictive Value of Tests Multivariate Analysis Case-Control Studies Risk Factors Fatal Outcome Follow-Up Studies Clinical Trials, Phase I as Topic Prospective Studies SEER Program Reproducibility of Results Treatment Refusal Societies, Medical Risk Assessment Chi-Square Distribution Cohort Studies Incidence Treatment Failure

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Adenocarcinoma Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Deoxycytidine Pancreaticoduodenectomy Pancreatectomy Adenocarcinoma, Mucinous CA-19-9 Antigen Tumor Markers, Biological Cell Line, Tumor Pancreas Immunohistochemistry Antimetabolites, Antineoplastic Pancreatic Ducts Pancreatitis, Chronic Gene Expression Regulation, Neoplastic Prognosis Adenocarcinoma, Papillary Mucin-4 Genes, ras Survival Rate Lung Neoplasms Treatment Outcome Keratin-7 Survival Analysis Pancreatitis Mice, Nude Adenocarcinoma, Bronchiolo-Alveolar Esophageal Neoplasms Tumor Cells, Cultured Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Neoplasm Staging Carcinoma in Situ Barrett Esophagus Smad4 Protein Kaplan-Meier Estimate Neoplasm Invasiveness Antigens, Neoplasm Stomach Neoplasms Neoplasm Metastasis Neoplasm Transplantation Tissue Array Analysis Combined Modality Therapy Retrospective Studies Fluorouracil Radiotherapy, Adjuvant Cell Proliferation Disease Progression Reverse Transcriptase Polymerase Chain Reaction Ampulla of Vater Pancreatic Juice Chemotherapy, Adjuvant Carcinoma, Acinar Cell Precancerous Conditions HMGA1a Protein Immunoenzyme Techniques Common Bile Duct Neoplasms GPI-Linked Proteins Chemoradiotherapy, Adjuvant Transplantation, Heterologous Colonic Neoplasms DNA, Neoplasm Mutation Lymphatic Metastasis Cardia Receptor, Epidermal Growth Factor RNA, Messenger Disease-Free Survival Neoplasm Proteins Cisplatin Gene Expression Profiling Apoptosis Tomography, X-Ray Computed Blotting, Western Endosonography Mucins Xenograft Model Antitumor Assays Drug Resistance, Neoplasm Carcinoma, Islet Cell Dithizone Carcinoma, Squamous Cell Mucin-1 ras Proteins Proportional Hazards Models HMGA Proteins Neoadjuvant Therapy Oligonucleotide Array Sequence Analysis Time Factors Carcinoembryonic Antigen Palliative Care Polymerase Chain Reaction Congresses as Topic Proto-Oncogene Proteins Antigens, CD24 Quinazolines Sensitivity and Specificity RNA, Neoplasm Antibodies, Monoclonal Esophagogastric Junction

No FAQ available that match "nsclc pancreatic adenocarcinoma"